heart disease prediction research paper ieee

Heart Disease Prediction Using Machine Learning

Ieee account.

• Change Username/Password
• Update Address

Purchase Details

• Payment Options
• Order History
• View Purchased Documents

Profile Information

• Communications Preferences
• Profession and Education
• Technical Interests
• US & Canada: +1 800 678 4333
• Worldwide: +1 732 981 0060
• Contact & Support
• About IEEE Xplore
• Accessibility
• Terms of Use
• Nondiscrimination Policy
• Privacy & Opting Out of Cookies

A not-for-profit organization, IEEE is the world's largest technical professional organization dedicated to advancing technology for the benefit of humanity. © Copyright 2024 IEEE - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

• View all journals
• My Account Login
• Explore content
• About the journal
• Publish with us
• Sign up for alerts
• Open access
• Published: 29 September 2020

Machine learning prediction in cardiovascular diseases: a meta-analysis

• Chayakrit Krittanawong 1 , 9 ,
• Hafeez Ul Hassan Virk 2 ,
• Sripal Bangalore 3 ,
• Zhen Wang 4 , 5 ,
• Kipp W. Johnson 6 ,
• Rachel Pinotti 7 ,
• HongJu Zhang 8 ,
• Scott Kaplin 9 ,
• Bharat Narasimhan 9 ,
• Takeshi Kitai 10 ,
• Usman Baber 9 ,
• Jonathan L. Halperin 9 &
• W. H. Wilson Tang 10  

Scientific Reports volume  10 , Article number:  16057 ( 2020 ) Cite this article

51k Accesses

191 Citations

29 Altmetric

Metrics details

• Cardiovascular diseases
• Computational biology and bioinformatics
• Machine learning

Several machine learning (ML) algorithms have been increasingly utilized for cardiovascular disease prediction. We aim to assess and summarize the overall predictive ability of ML algorithms in cardiovascular diseases. A comprehensive search strategy was designed and executed within the MEDLINE, Embase, and Scopus databases from database inception through March 15, 2019. The primary outcome was a composite of the predictive ability of ML algorithms of coronary artery disease, heart failure, stroke, and cardiac arrhythmias. Of 344 total studies identified, 103 cohorts, with a total of 3,377,318 individuals, met our inclusion criteria. For the prediction of coronary artery disease, boosting algorithms had a pooled area under the curve (AUC) of 0.88 (95% CI 0.84–0.91), and custom-built algorithms had a pooled AUC of 0.93 (95% CI 0.85–0.97). For the prediction of stroke, support vector machine (SVM) algorithms had a pooled AUC of 0.92 (95% CI 0.81–0.97), boosting algorithms had a pooled AUC of 0.91 (95% CI 0.81–0.96), and convolutional neural network (CNN) algorithms had a pooled AUC of 0.90 (95% CI 0.83–0.95). Although inadequate studies for each algorithm for meta-analytic methodology for both heart failure and cardiac arrhythmias because the confidence intervals overlap between different methods, showing no difference, SVM may outperform other algorithms in these areas. The predictive ability of ML algorithms in cardiovascular diseases is promising, particularly SVM and boosting algorithms. However, there is heterogeneity among ML algorithms in terms of multiple parameters. This information may assist clinicians in how to interpret data and implement optimal algorithms for their dataset.

Similar content being viewed by others

Pre-existing and machine learning-based models for cardiovascular risk prediction

Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population

Interpretable machine learning models for predicting in-hospital and 30 days adverse events in acute coronary syndrome patients in Kuwait

Introduction.

Machine learning (ML) is a branch of artificial intelligence (AI) that is increasingly utilized within the field of cardiovascular medicine. It is essentially how computers make sense of data and decide or classify a task with or without human supervision. The conceptual framework of ML is based on models that receive input data (e.g., images or text) and through a combination of mathematical optimization and statistical analysis predict outcomes (e.g., favorable, unfavorable, or neutral). Several ML algorithms have been applied to daily activities. As an example, a common ML algorithm designated as SVM can recognize non-linear patterns for use in facial recognition, handwriting interpretation, or detection of fraudulent credit card transactions 1 , 2 . So-called boosting algorithms used for prediction and classification have been applied to the identification and processing of spam email. Another algorithm, denoted random forest (RF), can facilitate decisions by averaging several nodes. While convolutional neural network (CNN) processing, combines several layers and apples to image classification and segmentation 3 , 4 , 5 . We have previously described technical details of each of these algorithms 6 , 7 , 8 , but no consensus has emerged to guide the selection of specific algorithms for clinical application within the field of cardiovascular medicine. Although selecting optimal algorithms for research questions and reproducing algorithms in different clinical datasets is feasible, the clinical interpretation and judgement for implementing algorithms are very challenging. A deep understanding of statistical and clinical knowledge in ML practitioners is also a challenge. Most ML studies reported a discrimination measure such as the area under an ROC curve (AUC), instead of p values. Most importantly, an acceptable cutoff for AUC to be used in clinical practice, interpretation of the cutoff, and the appropriate/best algorithms to be applied in cardiovascular datasets remain to be evaluated. We previously proposed the methodology to conduct ML research in medicine 6 . Systematic review and meta-analysis, the foundation of modern evidence-based medicine, have to be performed in order to evaluate the existing ML algorithm in cardiovascular disease prediction. Here, we performed the first systematic review and meta-analysis of ML research over a million patients in cardiovascular diseases.

This study is reported in accordance with the Preferred Reporting Information for Systematic Reviews and Meta-Analysis (PRISMA) recommendations. Ethical approval was not required for this study.

Search strategy

A comprehensive search strategy was designed and executed within the MEDLINE, Embase, and Scopus databases from database inception through March 15, 2019. One investigator (R.P.) designed and conducted the search strategy using input from the study’s principal investigator (C.K.). Controlled vocabulary, supplemented with keywords, was used to search for studies of ML algorithms and coronary heart disease, stroke, heart failure, and cardiac arrhythmias. The detailed strategy is available from the reprint author. The full search strategies can be found in the supplementary documentation.

Study selection

Search results were exported from all databases and imported into Covidence 9 , an online systematic review tool, by one investigator (R.P.). Duplicates were identified and removed using Covidence's automated de-duplication functionality. The de-duplicated set of results was screened independently by two reviewers (C.K. and H.V.) in two successive rounds to identify studies that met the pre-specified eligibility criteria. In the initial screening, two investigators (C.K. and H.V.) independently examined the titles and abstracts of the records retrieved from the search via the Covidence portal and used a standard extraction form. Conflicts were resolved through consensus and reviewed by other investigators. We included abstracts with sufficient evaluation data, including methodology, the definition of outcomes, and an appropriate evaluation matrix. Studies without any kind of validation (external validation or internal validation) were excluded. We excluded reviews, editorials, non-human studies, letters without sufficient data.

Data extraction

We extracted the following information, if possible, from each study: authors, year of publication, study name, test types, testing indications, analytic models, number of patients, endpoints (CAD, AMI, stroke, heart failure, and cardiac arrhythmias), and performance measures ((AUC, sensitivity, specificity, positive cases (the number of patients who used the AI and were positively diagnosed with the disease), negative cases (the number of patients who used the AI and were negative with the AI test), true positives, false positives, true negatives, and false negatives)). CAD was defined as coronary artery stenosis > 70% using angiography or FFR-based significance. Cardiac arrhythmias included studies involving bradyarrhythmias, tachyarrhythmias, atrial, and ventricular arrhythmias. Data extraction was conducted independently by at least two investigators for each paper. Extracted data were compared and reconciled through consensus. In case studies which did not report positive and negative cases, we manually calculated by standard formulae using statistics available in the manuscripts or provided by the authors. We contacted the authors if the data of interest were not reported in the manuscripts or abstracts. The order of contact originated with the corresponding author, followed by the first author, and then the last author. If we were unable to contact the authors as specified above, the associated studies were excluded from the meta-analysis (but still included it in the systematic review). We also excluded manuscripts or abstracts without sufficient evaluation data after contacting the authors.

Quality assessment

We created the proposed guidance quality assessment of clinical ML research based on our previous recommendation (Table 1 ) 6 . Two investigators (C.K. and H.V.) independently assessed the quality of each ML study by using our proposed guideline to report ML in medical literature (Supplementary Table S1 ). We resolved disagreements through discussion amongst the primary investigators or by involving additional investigators to adjudicate and establish a consensus. We scored study quality as low (0–2), moderate (2.5–5), and high quality (5.5–8) as clinical ML research.

Statistical analysis

We used symmetrical, hierarchical, summary receiver operating characteristic (HSROC) models to jointly estimate sensitivity, specificity, and AUC 10 . \({Sen}_{i}\) and \({Spc}_{i}\) denote the sensitivity and specificity of the i th study. \({\sigma }_{Sen}^{2}\) is the variance of \({\mu }_{Sen}\) and \({\sigma }_{Spc}^{2}\) is the variance of \({\mu }_{spc}\) .

The HSROC model for study i fits the following

\({\pi }_{i1}\) = \({Sen}_{i}\) and \({\pi }_{i0}\) =1- \({Spc}_{i}\) . \({X}_{ij}=-\frac{1}{2}\) when no disease and \({X}_{ij}=\frac{1}{2}\) for those with disease. And \({\theta }_{i}\) and \({\alpha }_{i}\) follow normal distribution.

We conducted subgroup analyses stratified by ML algorithms. We assessed the performances of a subgroup-specific and statistical test of interaction among subgroups. We performed all statistical analyses using OpenMetaAnalyst for 64-bit (Brown University), R version 3.2.3 (Metafor and Phia packages), and Stata version 16.1 (Stata Corp, College Station, Texas). The meta-analysis has been reported in accordance with the Meta-analysis of Observational Studies in Epidemiology guidelines (MOOSE) 11 .

Study search

The database searches between 1966 and March 15, 2019, yielded 15,025 results. 3,716 duplicates were removed by algorithms. After the screening process, we selected 344 articles for full-text review. After full text and supplementary review, we excluded 289 studies due to insufficient data to perform meta-analytic approaches despite contacting corresponding authors. Overall, 103 cohorts (55 studies) met our inclusion criteria. The disposition of studies excluded after the full-text review is shown in Fig.  1 .

Study design. This flow chart illustrates the selection process for published reports.

Study characteristics

Table 2 shows the basic characteristics of the included studies. In total, our meta-analysis of ML and cardiovascular diseases included 103 cohorts (55 studies) with a total of 3,377,318 individuals. In total, 12 cohorts  assessed cardiac arrhythmias (3,144,799 individuals), 45 cohorts are CAD-related (117,200 individuals), 34 cohorts are stroke-related (5,577 individuals), and 12 cohorts are HF-related (109,742 individuals). The characteristics of the included studies are listed in Table 2 . We performed post hoc sensitivity analysis, excluding each study, and found no difference among the results.

ML algorithms and prediction of CAD

For the CAD, 45 cohorts reported a total of 116,227 individuals. 10 cohorts used CNN algorithms, 7 cohorts used SVM, 13 cohorts used boosting algorithm, 9 cohorts used custom-built algorithms, and 2 cohorts used RF. The prediction in CAD was associated with pooled AUC of 0.88 (95% CI 0.84–0.91), sensitivity of 0.86 (95% CI 0.77–0.92), and specificity of 0.70 (95% CI 0.51–0.84), for boosting algorithms and pooled of AUC 0.93 (95% CI 0.85–0.97), sensitivity of 0.87 (95% CI 0.74–0.94), and specificity of 0.86 (95% CI 0.73–0.93) for custom-built algorithms (Fig. 2 ).

ROC curves comparing different machine learning models for CAD prediction. The prediction in CAD was associated with pooled AUC of 0.87 (95% CI 0.76–0.93) for CNN, pooled AUC of 0.88 (95% CI 0.84–0.91) for boosting algorithms, and pooled of AUC 0.93 (95% CI 0.85–0.97) for others (custom-built algorithms).

ML algorithms and prediction of stroke

For the stroke, 34 cohorts reported a total of 7,027 individuals. 14 cohorts used CNN algorithms, 4 cohorts used SVM, 5 cohorts used boosting algorithm, 2 cohorts used decision tree, 2 cohorts used custom-built algorithms, and 1 cohort used random forest (RF). For prediction of stroke, SVM algorithms had a pooled AUC of 0.92 (95% CI 0.81–0.97), sensitivity 0.57 (95% CI 0.26–0.96), and specificity 0.93 (95% CI 0.71–0.99); boosting algorithms had a pooled AUC of 0.91 (95% CI 0.81–0.96), sensitivity 0.85 (95% CI 0.66–0.94), and specificity 0.85 (95% CI 0.67–0.94); and CNN algorithms had a pooled AUC of 0.90 (95% CI 0.83–0.95), sensitivity of 0.80 (95% CI 0.70–0.87), and specificity of 0.91 (95% CI 0.77–0.97) (Fig. 3 ).

ROC curves comparing different machine learning models for stroke prediction. The prediction in stroke was associated with pooled AUC of 0.90 (95% CI 0.83–0.95) for CNN, pooled AUC of 0.92 (95% CI 0.81–0.97) for SVM algorithms, and pooled AUC of 0.91 (95% CI 0.81–0.96) for boosting algorithms.

ML algorithms and prediction of HF

For the HF, 12 cohorts reported a total of 51,612 individuals. 3 cohorts used CNN algorithms, 4 cohorts used logistic regression, 2 cohorts used boosting algorithm, 1 cohort used SVM, 1 cohort used in-house algorithm, and 1 cohort used RF. We could not perform analyses because we had too few studies (≤ 5) for each model.

ML algorithms and prediction of cardiac arrhythmias

For the cardiac arrhythmias, 12 cohorts reported a total of 3,204,837 individuals. 2 cohorts used CNN algorithms, 2 cohorts used logistic regression, 3 cohorts used SVM, 1 cohort used k-NN algorithm, and 4 cohorts used RF. We could not perform analyses because we had too few studies (≤ 5) for each model.

To the best of our knowledge, this is the first and largest novel meta-analytic approach in ML research to date, which drew from an extensive number of studies that included over one million participants, reporting ML algorithms prediction in cardiovascular diseases. Risk assessment is crucial for the reduction of the worldwide burden of CVD. Traditional prediction models, such as the Framingham risk score 12 , the PCE model 13 , SCORE 14 , and QRISK 15 have been derived based on multiple predictive factors. These prediction models have been implemented in guidelines; specifically, the 2010 American College of Cardiology/American Heart Association (ACC/AHA) guideline 16 recommended the Framingham Risk Score, the United Kingdom National Institute for Health and Care Excellence (NICE) guidelines recommend the QRISK3 score 17 , and the 2016 European Society of Cardiology (ESC) guidelines recommended the SCORE model 18 . These traditional CVD risk scores have several limitations, including variations among validation cohorts, particularly in specific populations such as patients with rheumatoid arthritis 19 , 20 . Under some circumstances, the Framingham score overestimates CVD risk, potentially leading to overtreatment 20 . In general, these risk scores encompass a limited number of predictors and omit several important variables. Given the limitations of the most widely accepted risk models, more robust prediction tools are needed to more accurately predict CVD burden. Advances in computational power to process large amounts of data has accelerated interest in ML-based risk prediction, but clinicians typically have limited understanding of this methodology. Accordingly, we have taken a meta-analytic approach to clarify the insights that ML modeling can provide for CVD research.

Unfortunately, we do not know how or why the authors of the analyzed studies selected the chosen algorithms from the large array of options available. Researchers/authors may have selected potential models for their databases and performed several models (e.g., running parallel, hyperparameter tuning) while only reporting the best model, resulting in overfitting to their data. Therefore, we assume the AUC of each study is based upon the best possible algorithm available to the associated researchers. Most importantly, pooled analyses indicate that, in general, ML algorithms are accurate (AUC 0.8–0.9 s) in overall cardiovascular disease prediction. In subgroup analyses of each ML algorithms, ML algorithms are accurate (AUC 0.8–0.9 s) in CAD and stroke prediction. To date, only one other meta-analysis of the ML literature has been reported, and the underlying concept was similar to ours. The investigators compared the diagnostic performance of various deep learning models and clinicians based on medical imaging (2 studies pertained to cardiology) 21 . The investigators concluded that deep learning algorithms were promising but identified several methodological barriers to matching clinician-level accuracy 21 . Although our work suggests that boosting models and support vector machine (SVM) models are promising for predicting CAD and stroke risk, further study comparing human expert and ML models are needed.

First, the results showed that custom-built algorithms tend to perform better than boosting algorithm for CAD prediction in terms of AUC comparison. However, there is significant heterogeneity among custom-built algorithms that do not disclose their details. The boosting algorithm has been increasingly utilized in modern biomedicine 22 , 23 . In order to implement in clinical practice, the essential stages of designing a model and interpretation need to be uniform 24 . For implementation in clinical practice, custom-built algorithms must be transparent and replicated in multiple studies using the same set of independent variables.

Second, the result showed that boosting algorithms and SVM provides similar pooled AUC for stroke prediction. SVMs and boosting shared a common margin to address the clinical question. SVM seems to perform better than boosting algorithms in patients with stroke perhaps due to discrete, linear data or a proper non-linear kernel that fits the data better with improved generalization. SVM is an algorithm designed for maximizing a particular mathematical function with respect to a given collection of data. Compared to the other ML methods, SVM is more powerful at recognizing hidden patterns in complicated clinical datasets 2 , 25 . Both boosting and SVM algorithms have been widely used in biomedicine and prior studies showed mixed results 26 , 27 , 28 , 29 , 30 . SVM seems to outperform boosting in image recognition tasks 28 , while boosting seems to be superior in omic tasks 27 . However, in subgroup analysis, using research questions or types of protocols or images showed no difference in algorithm predictions.

Third, for heart failure and cardiac arrhythmias, we could not perform meta-analytic approaches due to the small number of studies for each model. However, based on our observation in our systematic review, SVM seems to outperform other predictive algorithms in detecting cardiac arrhythmias, especially in one large study 31 . Interestingly, in HF, the results are inconclusive. One small study showed promising results from SVM 32 . CNN seems to outperform others, but the results are suboptimal 33 . Although we assumed all reported algorithms have optimal variables, technical heterogeneity exists in ML algorithms (e.g., number of folds for cross-validation, bootstrapping techniques, how many run time [epochs], multiple parameters adjustments). In addition, optimal cut off for AUC remained unclear in clinical practice. For example, high or low sensitivity/specificity for each test depends on clinical judgement based on clinically correlated. In general, very high AUCs (0.95 or higher) are recommended, and it is known that AUC 0.50 is not able to distinguish between true and false. In some fields such as applied psychology 34 , with several influential variables, AUC values of 0.70 and higher would be considered strong effects. Moreover, standard practice for ML practitioners recommended reporting certain measures (e.g., AUC, c-statistics) without optimal sensitivity and specificity or model calibration, while interpretation in clinical practice is challenging. For example, the difference in BNP cut off for HF patients could result in a difference in volume management between diuresis and IV fluid in pneumonia with septic shock.

Compared to conventional risk scores, most ML models shared a common set of independent demographic variables (e.g., age, sex, smoking status) and include laboratory values. Although those variables are not well-validated individually in clinical studies, they may add predictive value in certain circumstances. Head-to-head studies comparing ML algorithms and conventional risk models are needed. If these studies demonstrate an advantage of ML-based prediction, the optimal algorithms could be implemented through electronic health records (EHR) to facilitate application in clinical practice. The EHR implementation is well poised for ML based prediction since the data are readily accessible, mitigating dependency on a large number of variables, such as discrete laboratory values. While it may be difficult for physicians in resource-constrained practice settings to access the input data necessary for ML algorithms, it is readily implemented in more highly developed clinical environments.

To this end, the selection of ML algorithm should base on the research question and the structure of the dataset (how large the population is, how many cases exist,  how balanced the dataset is,  how many available variables there are, whether the data is longitudinal or not, if the clinical outcome is binary or time to event, etc.) For example, CNN is particularly powerful in dealing with image data, while SVM can reduce the high dimensionality of the dataset if the kernel is correctly chosen. While when the sample size is not large enough, deep learning methods will likely overfit the data.  Most importantly, this study's intent is not to identify one algorithm that is superior to others.

Limitations

Although the performance of ML-based algorithms seems satisfactory, it is far from optimal. Several methodological barriers can confound results and increase heterogeneity. First, technical parameters such as hyperparameter tuning in algorithms are usually not disclosed to the public, leading to high statistical heterogeneity. Indeed, heterogeneity measures the difference in effect size between studies. Therefore, in the present study, heterogeneity is inevitable as several factors can lead to this (e.g., fine-tuning models, hyperparameter selection, epochs). It is also a not good indicator to use as, in our HSROC model, we largely controlled the heterogeneity. Second, the data partition is also arbitrary because of no standard guidelines for utilization. In the present study, most included studies use 80/20 or 70/30 for training and validation sets. In addition, since the sample size for each type of CVD is small, the pooled results could potentially be biased. Third, feature selection methodologies, and techniques are arbitrary and heterogeneous. Fourth, due to the ambiguity of custom-built algorithms, we could not classify the type of those algorithms. Fifth, studies report different evaluation matrices (e.g., some did not report positive or negative cases, sensitivity/specificity, F-score, etc.). We did not report the confusion matrix for this meta-analytic approach as it required aggregation of raw numbers from studies without adjusting for difference between studies, which could result in bias. Instead, we presented pooled sensitivity and specificity using the HSROC model. Although ML algorithms are robust, several studies did not report complete evaluation metrics such as positive or negative cases, Beyes, bias accuracy, or analysis in the validation cohort since there are many ways to interpret the data  depending on the clinical context. Most importantly, some analyses did not correlate with the clinical context, which made it more difficult to interpret. The efficacy of meta-analysis is to increase the power of the study by using the same algorithms. In addition, clinical data are heterogeneous and usually imbalanced. Most ML research did not report balanced accuracy, which could mislead the readers. Sixth, we did not register the analysis in PROSPERO. Finally, some studies reported only the technical aspect without clinical aspects, likely due to a lack of clinician supervision.

Although there are several limitations to overcome to be able to implement ML algorithms in clinical practice, overall ML algorithms showed promising results. SVM and boosting algorithms are widely used in cardiovascular medicine with good results. However, selecting the proper algorithms for the  appropriate research questions, comparison to human experts, validation cohorts, and reporting of  all possible evaluation matrices are needed for study interpretation in the correct clinical context. Most importantly, prospective studies comparing ML algorithms to conventional risk models are needed. Once validated in that way, ML algorithms could be integrated with electronic health record systems and applied in clinical practice, particularly in high resources areas.

Noble, W. S. Support vector machine applications in computational biology. Kernel Methods Comput. Biol. 71 , 92 (2004).

Google Scholar  

Aruna, S. & Rajagopalan, S. A novel SVM based CSSFFS feature selection algorithm for detecting breast cancer. Int. J. Comput. Appl. 31 , 20 (2011).

Lakhani, P. & Sundaram, B. Deep learning at chest radiography: Automated classification of pulmonary tuberculosis by using convolutional neural networks. Radiology 284 , 574–582 (2017).

PubMed   Google Scholar  

Yasaka, K. & Akai, H. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: A preliminary study. Radiology 286 , 887–896 (2018).

Christ, P. F. et al. Automatic Liver and Lesion Segmentation in CT Using Cascaded Fully Convolutional Neural Networks and 3D Conditional Random Fields. International Conference on Medical Image Computing and Computer-Assisted Intervention 415–423 (Springer, Berlin, 2016).

Krittanawong, C. et al. Deep learning for cardiovascular medicine: A practical primer. Eur. Heart J. 40 , 2058–2073 (2019).

PubMed   PubMed Central   Google Scholar  

Krittanawong, C., Zhang, H., Wang, Z., Aydar, M. & Kitai, T. Artificial intelligence in precision cardiovascular medicine. J. Am. Coll. Cardiol. 69 , 2657–2664 (2017).

Krittanawong, C. et al. Future direction for using artificial intelligence to predict and manage hypertension. Curr. Hypertens. Rep. 20 , 75 (2018).

Covidence systematic review software. Melbourne AVHIAawcoAD.

Rutter, C. M. & Gatsonis, C. A. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat. Med. 20 , 2865–2884 (2001).

CAS   PubMed   Google Scholar  

Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 , 2008–2012 (2000).

Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 , 1837–1847 (1998).

Goff, D. C. Jr. et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63 , 2935–2959 (2014).

Conroy, R. M. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur. Heart J. 24 , 987–1003 (2003).

Hippisley-Cox, J. et al. Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2. BMJ (Clinical research ed) 336 , 1475–1482 (2008).

Greenland, P. et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122 , e584-636 (2010).

Hippisley-Cox, J., Coupland, C. & Brindle, P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study. BMJ (Clinical research ed) 357 , j2099 (2017).

Piepoli, M. F. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 37 , 2315–2381 (2016).

Kremers, H. M., Crowson, C. S., Therneau, T. M., Roger, V. L. & Gabriel, S. E. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study. Arthritis Rheum. 58 , 2268–2274 (2008).

Damen, J. A. et al. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: A systematic review and meta-analysis. BMC Med. 17 , 109 (2019).

Liu, X. et al. A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: A systematic review and meta-analysis. Lancet Digit. Health 1 , e271–e297 (2019).

Mayr, A., Binder, H., Gefeller, O. & Schmid, M. The evolution of boosting algorithms. From machine learning to statistical modelling. Methods Inf. Med. 53 , 419–427 (2014).

Buhlmann, P. et al. Discussion of “the evolution of boosting algorithms” and “extending statistical boosting”. Methods Inf. Med. 53 , 436–445 (2014).

Natekin, A. & Knoll, A. Gradient boosting machines, a tutorial. Front. Neurorobot. 7 , 21–21 (2013).

Noble, W. S. What is a support vector machine?. Nat. Biotechnol. 24 , 1565–1567 (2006).

Zhang H, & Gu C. Support vector machines versus Boosting.

Ogutu, J. O., Piepho, H. P. & Schulz-Streeck, T. A comparison of random forests, boosting and support vector machines for genomic selection. BMC Proc. 5 (Suppl 3), S11 (2011).

Sun, T. et al. Comparative evaluation of support vector machines for computer aided diagnosis of lung cancer in CT based on a multi-dimensional data set. Comput. Methods Programs Biomed. 111 , 519–524 (2013).

Huang, M.-W., Chen, C.-W., Lin, W.-C., Ke, S.-W. & Tsai, C.-F. SVM and SVM ensembles in breast cancer prediction. PLoS One 12 , e0161501–e0161501 (2017).

Caruana R, Karampatziakis N, & Yessenalina A. An empirical evaluation of supervised learning in high dimensions. In Proceedings of the 25th International Conference on Machine Learning: ACM , 2008, 96–103.

Hill, N. R. et al. Machine learning to detect and diagnose atrial fibrillation and atrial flutter (AF/F) using routine clinical data. Value Health 21 , S213 (2018).

Rossing, K. et al. Urinary proteomics pilot study for biomarker discovery and diagnosis in heart failure with reduced ejection fraction. PLoS One 11 , e0157167 (2016).

Golas, S. B. et al. A machine learning model to predict the risk of 30-day readmissions in patients with heart failure: A retrospective analysis of electronic medical records data. BMC Med. Inform. Decis. Mak. 18 , 44 (2018).

Rice, M. E. & Harris, G. T. Comparing effect sizes in follow-up studies: ROC Area, Cohen’s d, and r. Law Hum Behav. 29 , 615–620 (2005).

Download references

There was no funding for this work.

Author information

Authors and affiliations.

Section of Cardiology, Baylor College of Medicine, Houston, TX, USA

Chayakrit Krittanawong

Harrington Heart & Vascular Institute, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Hafeez Ul Hassan Virk

Department of Cardiovascular Diseases, New York University School of Medicine, New York, NY, USA

Sripal Bangalore

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA

Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA

Department of Genetics and Genomic Sciences, Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Kipp W. Johnson

Levy Library, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Rachel Pinotti

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA

HongJu Zhang

Department of Cardiovascular Diseases, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, Mount Sinai Heart, New York, NY, USA

Chayakrit Krittanawong, Scott Kaplin, Bharat Narasimhan, Usman Baber & Jonathan L. Halperin

Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA

Takeshi Kitai & W. H. Wilson Tang

You can also search for this author in PubMed   Google Scholar

Contributions

C.K., H.H., S.B., Z.W., K.W.J., R.P., H.Z., S.K., B.N., T.K., U.B., J.L.H., W.T. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: C.K., H.H., K.W.J., Z.W. Acquisition of data: C.K., H.H., R.P., H.J., T.K. Analysis and interpretation of data: B.N., Z.W. Drafting of the manuscript: C.K., H.H., S.B., U.B., J.L.H., T.W. Critical revision of the manuscript for important intellectual content: T.W., Z.W. Study supervision: C.K., T.W.

Corresponding author

Correspondence to Chayakrit Krittanawong .

Ethics declarations

Competing interests.

The authors declare no competing interests.

Additional information

Publisher's note.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary file1, rights and permissions.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ .

Reprints and permissions

About this article

Cite this article.

Krittanawong, C., Virk, H.U.H., Bangalore, S. et al. Machine learning prediction in cardiovascular diseases: a meta-analysis. Sci Rep 10 , 16057 (2020). https://doi.org/10.1038/s41598-020-72685-1

Download citation

Received : 27 April 2020

Accepted : 24 August 2020

Published : 29 September 2020

DOI : https://doi.org/10.1038/s41598-020-72685-1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

This article is cited by

Causal machine learning for predicting treatment outcomes.

• Stefan Feuerriegel
• Dennis Frauen
• Mihaela van der Schaar

Nature Medicine (2024)

Adverse Effects of Meditation: Autonomic Nervous System Activation and Individual Nauseous Responses During Samadhi Meditation in the Czech Republic

• Silvie Kotherová
• Jakub Cigán
• Milan Sepši

Journal of Religion and Health (2024)

Cardiovascular disease incidence prediction by machine learning and statistical techniques: a 16-year cohort study from eastern Mediterranean region

• Kamran Mehrabani-Zeinabad
• Nizal Sarrafzadegan

BMC Medical Informatics and Decision Making (2023)

Risk prediction of heart failure in patients with ischemic heart disease using network analytics and stacking ensemble learning

• Minghui Shen

Predictis: an IoT and machine learning-based system to predict risk level of cardio-vascular diseases

• Muhammad Nazrul Islam
• Kazi Rafid Raiyan
• Angshu Bikash Mandol

BMC Health Services Research (2023)

By submitting a comment you agree to abide by our Terms and Community Guidelines . If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Quick links

• Explore articles by subject
• Guide to authors
• Editorial policies

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Accessibility Links

• Skip to content
• Skip to search IOPscience
• Skip to Journals list
• Accessibility help
• Accessibility Help

Click here to close this panel.

Purpose-led Publishing is a coalition of three not-for-profit publishers in the field of physical sciences: AIP Publishing, the American Physical Society and IOP Publishing.

Together, as publishers that will always put purpose above profit, we have defined a set of industry standards that underpin high-quality, ethical scholarly communications.

We are proudly declaring that science is our only shareholder.

Heart disease prediction using machine learning algorithms

Harshit Jindal 1 , Sarthak Agrawal 1 , Rishabh Khera 1 , Rachna Jain 2 and Preeti Nagrath 2

Published under licence by IOP Publishing Ltd IOP Conference Series: Materials Science and Engineering , Volume 1022 , 1st International Conference on Computational Research and Data Analytics (ICCRDA 2020) 24th October 2020, Rajpura, India Citation Harshit Jindal et al 2021 IOP Conf. Ser.: Mater. Sci. Eng. 1022 012072 DOI 10.1088/1757-899X/1022/1/012072

Article metrics

46587 Total downloads

Share this article

Author e-mails.

[email protected]

Author affiliations

1 Student, Dept. Of Electronics And Communication Eng. Bharti Vidyapeeth's College Of Engineering, New Delhi

2 Faculty, Dept. Of Computer Science & Engineering Bharti Vidyapeeth's College Of Engineering, New Delhi

Buy this article in print

Day by day the cases of heart diseases are increasing at a rapid rate and it's very Important and concerning to predict any such diseases beforehand. This diagnosis is a difficult task i.e. it should be performed precisely and efficiently. The research paper mainly focuses on which patient is more likely to have a heart disease based on various medical attributes. We prepared a heart disease prediction system to predict whether the patient is likely to be diagnosed with a heart disease or not using the medical history of the patient. We used different algorithms of machine learning such as logistic regression and KNN to predict and classify the patient with heart disease. A quite Helpful approach was used to regulate how the model can be used to improve the accuracy of prediction of Heart Attack in any individual. The strength of the proposed model was quiet satisfying and was able to predict evidence of having a heart disease in a particular individual by using KNN and Logistic Regression which showed a good accuracy in comparison to the previously used classifier such as naive bayes etc. So a quiet significant amount of pressure has been lift off by using the given model in finding the probability of the classifier to correctly and accurately identify the heart disease. The Given heart disease prediction system enhances medical care and reduces the cost. This project gives us significant knowledge that can help us predict the patients with heart disease It is implemented on the.pynb format.

Export citation and abstract BibTeX RIS

Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence . Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.

Heart Disease Prediction and Diagnosis Using IoT, ML, and Cloud Computing

• Conference paper
• First Online: 26 October 2023
• Cite this conference paper

• Jyoti Maurya 13 &
• Shiva Prakash 13  

Part of the book series: Lecture Notes in Networks and Systems ((LNNS,volume 731))

Included in the following conference series:

• International Conference On Innovative Computing And Communication

146 Accesses

Heart disease is currently regarded as the main cause of illness. Regardless of age group, heart disease is a serious condition nowadays because most individuals are not aware of their kind and level of heart disease. In this fast-paced world, it is essential to be aware of the different types of cardiac problems and the routine disease monitoring process. As per the statistics from the World Health Organization, 17.5 million deaths are because of cardiovascular disease. Manual feature engineering, on the other hand, is difficult and generally requires the ability to choose the suitable technique. To resolve these issues, IoT, machine learning models and cloud techniques, are playing a significant role in the automatic disease prediction in medical field. SVM, Naive Bayes, Decision Tree, K-Nearest Neighbor, and Artificial Neural Network are some of the machine learning techniques used in the prediction of heart diseases. In this paper, we have described various research works, related heart disease dataset, and comparison and discussion of different machine learning models for prediction of heart disease and also described the research challenges, future scope and discussed the conclusion. The main goal of the paper is to review the latest and most relevant papers to identify the benefits, drawbacks, and research gaps in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

• Available as PDF
• Read on any device
• Instant download
• Own it forever
• Available as EPUB and PDF
• Compact, lightweight edition
• Dispatched in 3 to 5 business days
• Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Verma G, Prakash S (2021) Internet of things for healthcare: research challenges and future prospects. In: Advances in communication and computational technology, pp 1055–1067

Google Scholar  

Raj A, Prakash S, Srivastva J, Gaur R (2023) Blockchain-based intelligent agreement for healthcare system: a review. In: International conference on innovative computing and communications, pp 633–642

Bhagchandani K, Peter Augustine D (2019) IoT based heart monitoring and alerting system with cloud computing and managing the traffic for an ambulance in India. Int J Electr Comput Eng 9(6):5068–5074. https://doi.org/10.11591/ijece.v9i6.pp5068-5074

Verma G, Prakash S (2020) Pneumonia classification using deep learning in healthcare. Int J Innov Technol Explor Eng 9(4):1715–1723. https://doi.org/10.35940/ijitee.d1599.029420

Divya BN, Gowrika GN, Hamsa N (2022) Review on IoT based heart rate monitoring system. Int J Adv Res Sci Commun Technol 3(3):354–356. https://doi.org/10.48175/ijarsct-3129

Rai AK, Daniel AK (2021) Energy-efficient routing protocol for coverage and connectivity in WSN. In: Proceedings of 1st international conference advanced computing and communication technologies ICACFCT 2021, pp 140–145. https://doi.org/10.1109/ICACFCT53978.2021.9837364

Rai AK, Daniel AK (2021) An energy-efficient routing protocol using threshold hierarchy for heterogeneous wireless sensor network. Lect Notes Data Eng Commun Technol 57:553–570. https://doi.org/10.1007/978-981-15-9509-7_45

Article   Google Scholar  

He Q, Maag A, Elchouemi A (2020) Heart disease monitoring and predicting by using machine learning based on IoT technology. CITISIA 2020—IEEE conference on innovative technologies in intelligent systems and industrial applications, proceedings, pp 1–10. https://doi.org/10.1109/CITISIA50690.2020.9371772

Sharma R, Prakash S, Roy P (2020) Methodology, applications, and challenges of WSN-IoT. In: 2020 international conference on electrical and electronics engineering (ICE3), pp 502–507. https://doi.org/10.1109/ICE348803.2020.9122891

Umer M, Sadiq S, Karamti H, Karamti W, Majeed R, Nappi M (2022) IoT based smart monitoring of patients’ with acute heart failure. Sensors 22(7):1–18. https://doi.org/10.3390/s22072431

Maurya J, Kumari S, Tiwari S, Maurya P, Agrawal S, Face recognition attendance system using OpenCV

Gaur R, Prakash S, Kumar S, Abhishek K, Msahli M (2022) A machine-learning—blockchain-based authentication using, pp 1–19

Ganesan M, Sivakumar N (2019) IoT based heart disease prediction and diagnosis model for healthcare using machine learning models. In: 2019 IEEE international conference on system, computation, automation and networking, ICSCAN 2019, pp 1–5. https://doi.org/10.1109/ICSCAN.2019.8878850

Prakash S, Rajput A (2018) Hybrid cryptography for secure data communication in wireless sensor networks. Adv Intell Syst Comput 696:589–599. https://doi.org/10.1007/978-981-10-7386-1_50

Colak C, Karaman E, Turtay MG (2015) Application of knowledge discovery process on the prediction of stroke. Comput Methods Programs Biomed 119(3):181–185. https://doi.org/10.1016/j.cmpb.2015.03.002

Holman DV (1946) Diagnosis of heart disease. Med Bull 6(5):274–284. https://doi.org/10.1126/science.69.1799.0xiv

Sultana M, Haider A, Uddin MS (2017) Analysis of data mining techniques for heart disease prediction. In: 2016 3rd international conference on electrical engineering and information communication technology, iCEEiCT 2016. https://doi.org/10.1109/CEEICT.2016.7873142

Deepika K, Seema S (2017) Predictive analytics to prevent and control chronic diseases. In: Proceedings of 2016 2nd international conference on applied and theoretical computing and communication technology, iCATccT 2016, pp 381–386. https://doi.org/10.1109/ICATCCT.2016.7912028

Acharya UR et al (2017) Application of higher-order spectra for the characterization of Coronary artery disease using electrocardiogram signals. Biomed Signal Process Control 31:31–43. https://doi.org/10.1016/j.bspc.2016.07.003

Saqlain M, Hussain W, Saqib NA, Khan MA (2016) Identification of heart failure by using unstructured data of cardiac patients. In: Proceedings international conference on parallel process. Work, pp 426–431. https://doi.org/10.1109/ICPPW.2016.66

Davari Dolatabadi A, Khadem SEZ, Asl BM (2017) Automated diagnosis of coronary artery disease (CAD) patients using optimized SVM. Comput Methods Programs Biomed 138:117–126. https://doi.org/10.1016/j.cmpb.2016.10.011

Shah SMS, Batool S, Khan I, Ashraf MU, Abbas SH, Hussain SA (2017) Feature extraction through parallel probabilistic principal component analysis for heart disease diagnosis. Phys A Stat Mech Appl 482:796–807. https://doi.org/10.1016/j.physa.2017.04.113

Article   MATH   Google Scholar  

Chala Beyene M (2020) Survey on prediction and analysis the occurrence of heart disease using data mining techniques. 2018 Jan 2018 [Online]. Available: http://www.ijpam.eu

Nagamani T, Logeswari S, Gomathy B (2019) Heart disease prediction using data mining with Mapreduce algorithm. 3:137–140

Saw M, Saxena T, Kaithwas S, Yadav R, Lal N (2020) Estimation of prediction for getting heart disease using logistic regression model of machine learning. In: 2020 international conference on computer communication and informatics, ICCCI 2020, pp 20–25. https://doi.org/10.1109/ICCCI48352.2020.9104210

Patro SP, Nayak GS, Padhy N (2021) Heart disease prediction by using novel optimization algorithm: a supervised learning prospective. Inform Med Unlock 26. https://doi.org/10.1016/j.imu.2021.100696

Ashraf M et al (2021) Prediction of cardiovascular disease through cutting-edge deep learning technologies: an empirical study based on TENSORFLOW, PYTORCH and KERAS. Adv Intell Syst Comput 1165:239–255. https://doi.org/10.1007/978-981-15-5113-0_18

Absar N et al (2022) The efficacy of machine-learning-supported smart system for heart disease prediction. Healthc 10(6):1–19. https://doi.org/10.3390/healthcare10061137

Sandhiya S, Palani U (2022) An IoT enabled heart disease monitoring system using grey wolf optimization and deep belief network [Online]. Available: https://doi.org/10.21203/rs.3.rs-1058279/v1

Srivastava A, Singh AK (2022) Heart disease prediction using machine learning. In: 2022 2nd international conference on advance computing and innovative technologies in engineering ICACITE 2022, vol 9, no 04, pp 2633–2635. https://doi.org/10.1109/ICACITE53722.2022.9823584

Nancy AA, Ravindran D, Raj Vincent PMD, Srinivasan K, Gutierrez Reina D (2022) IoT-cloud-based smart healthcare monitoring system for heart disease prediction via deep learning. Electron 11(15):2292. https://doi.org/10.3390/electronics11152292

Download references

Author information

Authors and affiliations.

Department of Information Technology and Computer Application, Madan Mohan Malaviya University of Technology, Gorakhpur, Uttar Pradesh, 273010, India

Jyoti Maurya & Shiva Prakash

You can also search for this author in PubMed   Google Scholar

Corresponding author

Correspondence to Jyoti Maurya .

Editor information

Editors and affiliations.

IT Department, Cairo University, Giza, Egypt

Aboul Ella Hassanien

Tijuana Institute of Technology, Tijuana, Mexico

Oscar Castillo

Department of Computer Science, Shaheed Sukhdev College of Business Studies, University of Delhi, Delhi, India

Sameer Anand

Department of Computer Science, Shaheed Sukhdev College of Business Studies, University of Delhi, New Delhi, India

Ajay Jaiswal

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this paper

Cite this paper.

Maurya, J., Prakash, S. (2024). Heart Disease Prediction and Diagnosis Using IoT, ML, and Cloud Computing. In: Hassanien, A.E., Castillo, O., Anand, S., Jaiswal, A. (eds) International Conference on Innovative Computing and Communications. ICICC 2023. Lecture Notes in Networks and Systems, vol 731. Springer, Singapore. https://doi.org/10.1007/978-981-99-4071-4_33

Download citation

DOI : https://doi.org/10.1007/978-981-99-4071-4_33

Published : 26 October 2023

Publisher Name : Springer, Singapore

Print ISBN : 978-981-99-4070-7

Online ISBN : 978-981-99-4071-4

eBook Packages : Engineering Engineering (R0)

Share this paper

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

• Publish with us

Policies and ethics

• Find a journal
• Track your research